How to use the speech recognition tool?
Retinitis pigmentosa: molecular diagnosis by next generation sequencing
Retinitis pigmentosa: molecular diagnosis by next generation sequencing.
Status of the trial: Completed
Orphan Drug Recognition: No
- Opening Date: 2013-06-18
- Closing Date: 2016-09-19
Inclusion: probands or family pedigrees with inherited retinal dystrophy
Exclusion: patients or family pedigrees with retinal abnormalities mimiking inherited retinal dystrophy
Funder Type: public
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
- Retinal Rare Eye Diseases (WG1)
This ERN is supported by:
Instagram Ern-EyeFacebook Ern-EyeTwitter Ern-EyeLinkedIn Ern-EyeYouTube Ern-Eye